Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 221

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 221
---
 non-executive directors during 2024:

| Name                      |     | Number of 
 Options   |            |     | Grant     
 Date      |     | Exercise Price 
 per Share      
 (£)            |       |     | Expiration 
 Date       |
| Sijmen de Vries, M.D. (1) |     |           | 28,800,000 |     | 1/23/2024 |     | £              | 0.004 |     | 1/23/2034  |
| Simon Turton, Ph.D. (1)   |     |           | 28,800,000 |     | 1/23/2024 |     | £              | 0.004 |     | 1/23/2034  |
| Ann Merchant (1)          |     |           | 28,800,000 |     | 1/23/2024 |     | £              | 0.004 |     | 1/23/2034  |
| Stephen Parker (1)        |     |           | 57,600,000 |     | 1/23/2024 |     | £              | 0.004 |     | 1/23/2034  |

___________

| (1) | The stock options vest in the following 25% of the options vest 12                                                                              
 months after the grant date, and the remaining options have subsequently vested, or will vest, in 12 equal quarterly tranches over a subsequent 
 three-year period.                                                                                                                              |

All stock options were granted
with an exercise price at or above market value on the date of grant.

Deed of Indemnity

Under a deed poll declared
by the Company on August 5, 2015, or a Deed of Indemnity, the Board of Directors and our Company Secretary are indemnified against costs
and liabilities incurred in connection with their office, other than any liability owed by such person to the Company itself (or any of
its associated entities) and other than indemnification for liabilities in certain circumstances, which are prohibited by virtue of the
Companies Act. The Deed of Indemnity provides that a director may also be lent sums to finance any relevant defense costs, provided that,
in the event such proceedings involve criminal or civil matters in which the person is convicted or has a judgment made against him or
her, then such loan must be repaid.

Letters of